August 23, 2014 4:13 PM ET


Company Overview of Oncalis AG

Company Overview

Oncalis AG engages in the discovery and development of small molecule inhibitors for oncology indications. The company was founded in 2006 and is based in Schlieren, Switzerland. Oncalis AG was a prior subsidiary of ESBATech AG.

Wagistr. 21

Schlieren,  8952


Founded in 2006


41 44 733 49 00

Key Executives for Oncalis AG

Chief Executive Officer and Vice Chairman
Chief Financial Officer
Vice President of Drug Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Acino Pharma AG Europe
Serono Technologies S.A. Europe
Metriopharm AG Europe
Laboratoire Sanoflore SA Europe
Robapharm Sa Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oncalis AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at